Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia

Background. The burden of Kaposi sarcoma (KS) in human immunodeficiency virus (HIV)–infected children and adolescents on combination antiretroviral therapy (cART) has not been compared globally. Methods. We analyzed cohort data from the International Epidemiologic Databases to Evaluate AIDS and the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:CLINICAL INFECTIOUS DISEASES 2016-11, Vol.63 (9), p.1245-1253
Hauptverfasser: Rohner, Eliane, Schmidlin, Kurt, Zwahlen, Marcel, Chakraborty, Rana, Clifford, Gary, Obel, Niels, Grabar, Sophie, Verbon, Annelies, Noguera-Julian, Antoni, Collins, Intira Jeannie, Rojo, Pablo, Brockmeyer, Norbert, Campbell, Maria, Chêne, Geneviève, Prozesky, Hans, Eley, Brian, Stefan, D Cristina, Davidson, Alan, Chimbetete, Cleophas, Sawry, Shobna, Davies, Mary-Ann, Kariminia, Azar, Vibol, Ung, Sohn, Annette, Egger, Matthias, Bohlius, Julia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background. The burden of Kaposi sarcoma (KS) in human immunodeficiency virus (HIV)–infected children and adolescents on combination antiretroviral therapy (cART) has not been compared globally. Methods. We analyzed cohort data from the International Epidemiologic Databases to Evaluate AIDS and the Collaboration of Observational HIV Epidemiological Research in Europe. We included HIV-infected children aged
ISSN:1058-4838
1537-6591
1537-6591
DOI:10.1093/cid/ciw519